Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Soligenix, Inc.
Unilever, which has had three offers for GSK rebuffed, likely notes that the Federal Trade Commission and Department of Justice signal they will tighten scrutiny of deals that merge companies providing consumer-facing products and services.
The approval of Fyarro marks the first for advanced malignant PEComa, a rare cancer that affects only 100-300 people in the US; it's also the first launch for Aadi Biosciences.
J&J failed to convince BBB National Program’s appeals panel a 2008 NAD decision supporting its “#1 dermatologist recommended” claim for Neutrogena should preclude another review. Panel says market has changed in 12 years since review of Unilever challenge and L’Oreal could make its own challenge.
Quality and the measure of a firm: Toyobo’s particulates and resins, Galenicko’s sanitation, Breckenridge’s product chemistry and Fujifilm’s cross-contamination risk.
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Biological Therapeutics, Inc.
- DOR BioPharma, Inc.
- Endorex Corporation
- Enteron Pharmaceuticals
- Immunotherapeutics Inc.